Benylan

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benylan

Quick Facts

Property Description
Active Ingredient Diphenhydramine hydrochloride
Form Oral liquid (Syrup, Elixir)
Pharmacological Class First-generation H1 receptor antagonist, Antitussive
General Purpose Relief of cough and associated common cold irritation
Origin Synthetic

What Type of Medicine is Benylan and How is it Classified?

Benylan is a synthetic pharmaceutical preparation classified primarily as a first-generation H1 receptor antagonist (antihistamine) with simultaneous antitussive properties. Its defining active ingredient is Diphenhydramine hydrochloride (Diphenhydramine HCl). This substance acts centrally to depress the cough center in the brain, supporting its utility as an antitussive. Unlike newer, often non-sedating antihistamines, its first-generation status means it readily enters the central nervous system, which contributes to a notable sedative effect in addition to its primary action of blocking the inflammatory compound histamine.

What is the Active Ingredient and Form of Benylan?

The preparation's primary efficacy is derived from its main active ingredient, Diphenhydramine hydrochloride, delivered as an oral liquid (syrup or elixir) intended for oral administration. The Benylan brand has been positioned to address cough symptoms, often featuring a distinct flavor profile designed for palatability, making it a recognized choice for patient groups who prefer liquid pharmaceutical preparations over tablets. The preparation is technically classified as a combination product, consisting of the active ingredient dissolved in an aqueous vehicle that includes excipients such as Sucrose, Liquid glucose, and minor amounts of Ethanol (alcohol). Diphenhydramine is an established medicine recognized for its anti-allergic and sedative properties.

What General Purpose Does Diphenhydramine Serve in This Preparation?

The general purpose of this preparation is to provide comprehensive relief of cough and the associated irritation, most often experienced with common cold symptoms. The Diphenhydramine component achieves this benefit through a systemic effect: it reduces the impact of circulating histamine by acting as an H1 receptor antagonist, while simultaneously suppressing the cough reflex. This dual action on both peripheral irritation and the central cough center efficiently intervenes in the cycle of involuntary coughing, such as during a typical nighttime episode where persistent irritation prevents rest.

Regulatory References

  1. WHO Model Lists of Essential Medicines

What side effects are possible with Benylan?

Possible Side Effects and Safety Information

Benylan (diphenhydramine) has a safety profile primarily characterized by its effects on the central nervous system (CNS) and its anticholinergic properties. The most frequent adverse reactions documented in regulatory labeling are related to CNS depression and include sedation, sleepiness, dizziness, and disturbed coordination. Other commonly reported effects involve the gastrointestinal system and general issues such as dryness of the mouth, nose, and throat.

Serious Safety Considerations

Serious adverse reactions that have been officially documented include anaphylactic shock and convulsions. Taking higher than recommended doses is specifically warned against by the U.S. Food and Drug Administration (FDA) because it can lead to severe health issues, including serious heart problems, seizures, coma, or death.

Restrictions and Population-Specific Warnings

Benylan is officially contraindicated in neonates or premature infants and for use in nursing mothers due to the higher potential for serious adverse effects in these populations. The drug should not be used by patients with specific pre-existing conditions, such as narrow-angle glaucoma, stenosing peptic ulcer, symptomatic prostatic hypertrophy, or bladder-neck obstruction.

Caution is advised in the elderly (60 years or older) as they are more likely to experience effects like dizziness, sedation, and hypotension. Due to the potential for diminished mental alertness and its additive effect with alcohol and other CNS depressants, patients are officially warned against engaging in activities requiring full alertness after use.

Overdose and Emergency Response

The official regulatory profile for an overdose of Benylan (Diphenhydramine hydrochloride) details specific clinical manifestations and mandates immediate emergency action. Overdose presentations can vary widely, encompassing symptoms of CNS stimulation, such as agitation, hallucinations, delirium, and even seizures. Conversely, toxicity may result in CNS depression, manifesting as extreme somnolence or coma. Physical signs of toxicity often include the anticholinergic syndrome, characterized by symptoms like mydriasis (dilated pupils) and dry mouth.

Regulatory sources warn that taking higher than recommended doses can lead to severe, life-threatening outcomes, including serious heart problems such as arrhythmias, cardiovascular collapse, and ultimately death.

Immediate medical attention must be sought if an individual exhibits severe signs such as inability to be awakened, experiencing a seizure, having trouble breathing, or has collapsed.

Management is strictly symptomatic and supportive. While no specific antidote is known, officially documented procedures may include the use of activated charcoal and the administration of parenteral diazepam to manage convulsions. Population-specific considerations note that children are particularly prone to CNS stimulation, while elderly patients may exhibit increased confusion or paradoxical excitation.

Therapeutic Uses of Benylan

The Benylan preparation (containing Diphenhydramine hydrochloride) is commonly used across conditions presenting with acute episodes to provide symptomatic relief by addressing symptoms related to inflammatory or irritative states often associated with the common cold. The preparation is relevant when supportive symptom management is appropriate for cough and cold symptoms.

It is applied across therapeutic domains where additional symptomatic support is needed, particularly for the dry, non-productive cough stemming from minor irritation. Benylan is commonly used to help manage persistent coughing episodes, providing relief for symptoms related to physical discomfort.

The preparation helps manage symptoms that create noticeable physiological strain and is applicable for conditions presenting with symptomatic discomfort, such as minor throat irritation, sneezing, and runny nose. It is often used during phases when symptoms intensify and supportive relief is needed, especially when symptoms interfere with routine activities.

Quick Fact: Symptomatic Relief The preparation is applied in scenarios where the dry, hacking cough and its associated airway irritation temporarily overwhelm comfort, providing supportive relief when symptoms interfere with routine activities and supporting general well-being.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility Profile for Benylan

Regulatory documentation defines strict population eligibility rules for Diphenhydramine hydrochloride (Benylan's active ingredient), establishing absolute contraindications and requirements for conditional use in vulnerable groups.

Eligibility Status Populations and Conditions
Absolutely Contraindicated Neonates, Premature Infants, and Nursing Mothers (Breastfeeding Women). Individuals with known Hypersensitivity to Diphenhydramine or related antihistamines.
Conditional/Caution Required Patients with Narrow-Angle Glaucoma, Stenosing Peptic Ulcer, Pyloroduodenal Obstruction, or Bladder-Neck Obstruction. Caution is also necessary for patients with a history of Bronchial Asthma, Hyperthyroidism, or Cardiovascular Disease.

Age-Related Eligibility

Nonprescription cough and cold products containing this ingredient should not be given to children younger than 2 years of age. Use in older adults (approximately 60 years or older) is restricted, as they are more likely to experience effects like dizziness and sedation. For pregnancy, the drug is classified as Category B by the FDA, indicating use is only appropriate if clearly needed.

What should I know about interactions with other medicines?

Benylan's active ingredient, Diphenhydramine hydrochloride, has a defined interaction profile established by regulatory documents, driven primarily by pharmacodynamic effects. A Contraindicated Combination exists with Monoamine Oxidase Inhibitors (MAOIs). Official regulatory guidelines strictly prohibit the use of Diphenhydramine within 14 days of beginning or discontinuing MAOI therapy. This specific timing-based restriction is necessary because MAOIs are formally documented to prolong and intensify the anticholinergic effects of the drug.

The second core interaction involves Additive Central Nervous System (CNS) Depression. Co-administration with Alcohol or other CNS depressant medications, including hypnotics, sedatives, and tranquilizers, is restricted due to this potent additive effect, which is classified as a clinically significant pharmacodynamic interaction. Additionally, the official labeling notes that in the Elderly (60 years and older) population, monitoring may be required for heightened anticholinergic effects when Diphenhydramine is used near MAOIs. Regarding substances without medicinal action, the use of Alcohol is formally restricted due to the documented additive CNS effects. Regulatory sources state that there are no known interactions between the active ingredient and standard food or nonalcoholic drinks. This structure dictates precise constraints on co-administration based on the risk classifications documented in official drug labels.

Mechanism of Action

The action of Diphenhydramine hydrochloride is characterized by simultaneous effects across three distinct pharmacological domains, each contributing to a change in the body's physiological signaling.

Central Suppression of the Cough Arc

This mechanism involves the molecule's high lipophilicity, which allows rapid entry into the Central Nervous System (CNS), where it acts as a non-specific depressant on the Central Cough Center in the brainstem. By modulating neuronal excitability within this center, the drug increases the threshold required for an incoming sensory stimulus to activate the efferent pathway of the cough arc.

Dual H1 Receptor Antagonism

The molecule functions as a competitive antagonist at the Histamine H1 Receptor ( H1 R), blocking the binding of endogenous histamine both centrally and peripherally. Peripherally, this action limits the histamine-driven increase in vascular permeability and modulates activity at local sensory nerve endings, influencing the afferent signals that excite the central cough arc.

Modulation of Cholinergic and H1 CNS Signaling

In the CNS, the combined blockade of H1 R and Muscarinic Acetylcholine Receptors (mAChR) (an anticholinergic action) interferes with signaling pathways responsible for arousal and wakefulness. This non-selective central receptor occupation results in generalized CNS depression and subsequent somnolence.

Dosage and Administration Information

How Benylan is Used: Official Administration Guidelines

Benylan, an oral liquid solution containing Diphenhydramine hydrochloride, is administered strictly via the oral route. The official use protocol is defined by standardized dosage, frequency, and specific administration requirements.

Standard Dosage and Frequency

The established dosing regimen dictates the amount and frequency based on age group. For accurate administration, the dose must be measured using a calibrated dosing device, such as the cup supplied with the product. The medication may be taken with or without food.

Age Group Single Dose Range Frequency Interval Maximum Daily Limit
Adults (12+ years) 25 mg to 50 mg Every 4 to 6 hours Not to exceed 6 doses
Children (6 to under 12) 12.5 mg to 25 mg Every 4 to 6 hours Not to exceed 6 doses

Procedural Requirements and Timeframe

This preparation is intended for as-needed (PRN) use for temporary relief. If a dose is missed, the subsequent dose should be taken only when needed, maintaining the minimum 4 to 6 hour interval since the last administration; a double dose must not be taken. The preparation is not for self-medication in children under 6 years of age. Due to physiological differences in drug clearance, a lower initial dose is officially advisable for older adults. These defined principles structure the official protocol for using the preparation.

Recent Clinical Evidence

Research evidence / Overview of Studies for Benylan (Diphenhydramine)


Research Supporting Use for Acute Irritative Cough

Research examined the component, Diphenhydramine, for its potential role in cough associated with conditions associated with acute or disruptive episodes, such as cough that comes with the common cold. The evidence base includes Randomized Controlled Trials (RCTs) and systematic reviews that research examined outcomes related to outcomes linked to inflammatory or irritative states.

Studies was observed in adult populations during periods of increased symptom activity to explore how symptoms change over time. In laboratory settings, single-dose measurements was studied for their effect on the cough reflex. Research explored changes in the cough reflex, a physiological outcome. However, short-term clinical trials observed that measured changes in cough frequency were not always consistent when compared against placebo.


What Researchers Measured in Clinical Trials

To understand the evidence base, researchers studies explored two main types of outcomes. One type involved outcomes related to physiological strain or stress, such as the measurement of the cough reflex threshold. This physiological outcome was used in research exploring how symptoms change over time.

The second set of outcomes were patient-reported outcomes describing perceived discomfort. Studies monitored self-reported measures of cough severity, cough frequency ratings, and how much a nocturnal cough affects sleep quality. Most of the data research describes these outcomes following single-dose evaluations or very short-term trials lasting only a few days. The follow-up durations were limited in many of the key studies.


Evidence for Use in Specific Groups

Research was evaluated in various patient groups. Specifically, studies was observed in children with acute cough to monitor outcomes related to physical discomfort and sleep quality. When compared to a control substance or placebo, the evidence for children reported that the measured change in cough severity and sleep quality was comparable between the active preparation group and the control groups. This indicates that data for certain groups remain insufficient or reported limited difference in measured outcomes compared to placebo.


Consistency and Quality of the Evidence

Systematic reviews have noted that the consistency of the evidence is variable, and certainty of findings is associated with a low to moderate grade. Evidence quality varies across studies, and some older trials research highlights changes measured during the study period but are noted as having methodological limitations.


Research Gaps and Areas of Uncertainty

There are specific areas where the research record remains incomplete. Long-term effects are not fully established, as most trials focused on acute, short-term relief during a common cold episode. Therefore, there is limited information for long-term outcomes or how the medicine performs over extended periods. Some studies have been noted for modest sample sizes, and consistency of the evidence is variable.

Frequently Asked Questions (FAQ)

Common questions about Benylan (FAQ)

Q: How quickly should Benylan start working after I take it?

A: According to official product information, the medicine generally begins to take effect relatively quickly. The onset of action for the oral form is typically described as starting within 15 to 30 minutes after a dose is taken.


Q: How long does the effect of Benylan usually last?

A: The effects of Benylan are temporary. Regulatory documentation indicates that the symptomatic relief from a single dose usually lasts for approximately four to six hours. This duration corresponds to the typical minimum interval between doses.


Q: Can Benylan affect my ability to drive or operate machinery?

A: Regulatory patient information describes the potential for impaired driving or operating machinery. Due to possible sleepiness and dizziness resulting from its effect on the central nervous system, official labeling advises against these activities until the effects of the medicine are understood.


Q: Is Benylan known to cause dry mouth or dry eyes?

A: Yes, dry mouth is a commonly reported side effect. This is linked to the medicine’s anticholinergic properties, which can interfere with certain nerve signals in the body. Dry eyes are a related, though less common, effect that may also be reported.


Q: Is it normal to feel a little dizzy after taking Benylan?

A: Official documents list dizziness and lightheadedness among the common possible side effects. These feelings are associated with the medicine’s sedating effect on the central nervous system.


Q: Are there different strengths or formulations of Benylan available?

A: The active ingredient in Benylan is available in various formulations, not just the liquid solution. These different regulatory-defined formulations can include tablets and capsules, with multiple strengths defined by regulatory agencies.


Q: Can Benylan interact with common antidepressants?

A: Regulatory sources advise that Benylan can interact with certain types of antidepressants, including tricyclic antidepressants and some SSRI medications. This may increase the risk of side effects like confusion and dizziness due to additive effects on the central nervous system.


Q: Can Benylan cause changes in mood or behavior?

A: Official labeling states that reactions affecting mood or behavior have been reported. These can include confusion, agitation, or restlessness, and are noted to occur more frequently in older adults and children.


Q: Can Benylan cause difficulty urinating?

A: Difficulty urinating, which is clinically referred to as urinary retention, is a possible side effect of Benylan. This effect is specifically due to the medicine's anticholinergic action.


Q: Is it true that Benylan can sometimes cause restlessness instead of sleepiness?

A: Official warnings describe a potential for paradoxical excitation, especially in children. This means that instead of feeling sleepy, some individuals may experience the opposite effect, such as restlessness, irritability, or agitation.


Q: Are there any known interactions between Benylan and herbal supplements?

A: Regulatory guidance describes the need for caution when co-administering with herbal or complementary supplements. This is primarily a concern if the supplements have their own sedative or anticholinergic properties, which could lead to unintended additive effects.


Q: Is Benylan safe to use if I have kidney problems?

A: Official sources state that individuals with pre-existing kidney problems are a population that requires caution. Guidance from a health professional is needed prior to use to determine appropriateness.


Q: Is Benylan safe to use if I have liver problems?

A: Regulatory documents state that individuals with liver problems are a population that requires caution. Guidance from a health professional is needed prior to use.


Q: What is the recommended period of time to use Benylan?

A: Official guidelines describe the drug as being intended for short-term, temporary relief. Its self-medication use limits are defined as typically no more than seven days for allergy/cough or ten nights for sleep difficulty.


Q: Can Benylan cause stomach upset or nausea?

A: Yes, regulatory listings of possible side effects include common gastrointestinal symptoms. These can include feeling nauseous and experiencing general stomach upset.


Q: Why do official documents sometimes mention 'paradoxical excitement' with Benylan?

A: Official documents include 'paradoxical excitement' as a recognized, though uncommon, adverse effect. It is mentioned to formally describe that the medicine may occasionally cause central nervous system stimulation instead of the expected sedation.


Q: Do studies suggest Benylan is effective for its main purpose?

A: The drug is officially approved and indicated by regulatory bodies for the temporary relief of cough, allergy, and cold symptoms. This approval is based on clinical evidence reviewed during the drug authorization process.


Q: Can taking Benylan make my symptoms worse?

A: Regulatory guidance states that if symptoms worsen during use, it is a recognized signal that a consultation with a health professional is warranted.


Q: Is Benylan used for purposes other than cough or allergies?

A: Official product indications include use for the temporary relief of occasional sleep difficulty and the prevention or treatment of motion sickness, in addition to cough and allergy relief.


Q: Do you need a prescription to buy Benylan?

A: Benylan is commonly available for purchase without a prescription for its approved uses in allergy, cough, and sleep relief. It is generally classified as an Over-The-Counter (OTC) medication.


Q: Is Benylan known to cause heart palpitations?

A: Official documentation notes that cardiovascular adverse effects have been reported. These include experiencing a fast heartbeat or feeling palpitations.


Q: Is Benylan generally safe for short-term use?

A: The drug is authorized for sale as an over-the-counter medication intended for short-term, temporary relief of symptoms. Its general safety for brief use is defined by the conditions and warnings found in the official labeling.


Q: Is there a generic version of Benylan available?

A: Yes, the active ingredient in Benylan, Diphenhydramine, is one of the most widely available medications. Generic versions containing the same active substance are commonly available.


Q: Is it safe to use Benylan while breastfeeding (general information)?

A: Authoritative sources indicate that small, occasional doses carry a lower level of risk to breastfed infants. However, caution is always recommended, particularly with higher doses or prolonged use, as it may potentially affect the infant or milk supply.


Q: What does the patient leaflet say about Benylan's side effects?

A: The official patient leaflet summarizes that common side effects can include drowsiness, dizziness, dry mouth, and nausea. It also details less common effects like changes in mood or behavior.


Q: Can Benylan affect the results of an allergy skin test?

A: Regulatory guidance indicates that the medicine must be discontinued for a specified time before an allergy skin test is performed, as the drug can interfere with the accuracy of the results.


Q: Does Benylan have any known long-term side effects?

A: Studies and regulatory documents have reported potential side effects associated with chronic or long-term use. These can include cognitive issues, memory problems, blurred vision, and constipation, especially in older adults.


Q: Is Benylan commonly used for insomnia?

A: The drug is officially approved and indicated for the temporary relief of occasional sleep difficulty, which is another term for insomnia.

How should Benylan be stored and disposed of?

The official storage and disposal guidelines for Benylan (Diphenhydramine hydrochloride) are mandated to ensure product stability and safety.

Storage Requirements

The medicine must be stored at Controlled Room Temperature, defined as 20 C to 25 C. It is mandatory to protect the product from freezing and protect from light. Benylan should be kept in its original container and the container must remain tightly closed.

Disposal and Safety

All forms of the medicine must be kept out of the sight and reach of children.

Unused or expired product should be disposed of primarily through a drug take-back program. If one is unavailable, the medicine must be mixed with an undesirable substance, sealed in a bag, and then placed in the household trash. The product must not be poured into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Benylan found in:

A-Z Index: